1. Home
  2. EHAB vs FATE Comparison

EHAB vs FATE Comparison

Compare EHAB & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHAB
  • FATE
  • Stock Information
  • Founded
  • EHAB 2014
  • FATE 2007
  • Country
  • EHAB United States
  • FATE United States
  • Employees
  • EHAB N/A
  • FATE N/A
  • Industry
  • EHAB Hospital/Nursing Management
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EHAB Health Care
  • FATE Health Care
  • Exchange
  • EHAB Nasdaq
  • FATE Nasdaq
  • Market Cap
  • EHAB 397.2M
  • FATE 406.5M
  • IPO Year
  • EHAB N/A
  • FATE 2013
  • Fundamental
  • Price
  • EHAB $7.35
  • FATE $2.02
  • Analyst Decision
  • EHAB Hold
  • FATE Buy
  • Analyst Count
  • EHAB 6
  • FATE 11
  • Target Price
  • EHAB $9.15
  • FATE $6.89
  • AVG Volume (30 Days)
  • EHAB 402.1K
  • FATE 1.6M
  • Earning Date
  • EHAB 11-06-2024
  • FATE 11-12-2024
  • Dividend Yield
  • EHAB N/A
  • FATE N/A
  • EPS Growth
  • EHAB N/A
  • FATE N/A
  • EPS
  • EHAB N/A
  • FATE N/A
  • Revenue
  • EHAB $1,037,200,000.00
  • FATE $13,447,000.00
  • Revenue This Year
  • EHAB $2.55
  • FATE N/A
  • Revenue Next Year
  • EHAB $3.63
  • FATE N/A
  • P/E Ratio
  • EHAB N/A
  • FATE N/A
  • Revenue Growth
  • EHAB N/A
  • FATE N/A
  • 52 Week Low
  • EHAB $6.85
  • FATE $1.96
  • 52 Week High
  • EHAB $11.74
  • FATE $8.83
  • Technical
  • Relative Strength Index (RSI)
  • EHAB 45.67
  • FATE 31.10
  • Support Level
  • EHAB $6.93
  • FATE $2.33
  • Resistance Level
  • EHAB $8.09
  • FATE $2.58
  • Average True Range (ATR)
  • EHAB 0.35
  • FATE 0.25
  • MACD
  • EHAB 0.02
  • FATE -0.04
  • Stochastic Oscillator
  • EHAB 35.71
  • FATE 6.45

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: